Beyond LDL Cholesterol in Assessing Cardiovascular Risk: apo B or LDL-P?

被引：15
|
作者：
Master, Stephen R. [1 ,4 ]
Rader, Daniel J. [2 ,3 ,4 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
来源：
CLINICAL CHEMISTRY | 2013年 / 59卷 / 05期
关键词：
HIGH-DENSITY-LIPOPROTEIN; DISEASE; METAANALYSIS; PREDICTION; MARKERS;
D O I：
10.1373/clinchem.2013.203208
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：723 / 725
页数：3
相关论文
共 50 条
  • [1] Navigating Lipid Discrepancies: Implications for Cardiovascular Risk With LDL, Non-HDL, LDL-P, and ApoB
    Hassan, Sharjeel
    Triffon, Douglas W.
    CIRCULATION, 2024, 149
  • [2] LDL-cholesterol, apolipoprotein B and cardiovascular risk
    Frey, J
    Couderc, R
    ANNALES DE BIOLOGIE CLINIQUE, 1998, 56 (05) : 517 - 520
  • [3] DISCORDANCE IN LOW-DENSITY LIPOPROTEIN PARTICLE NUMBER (LDL-P) AND APOLIPOPROTEIN B (APO B) LEVEL
    Morris, Pamela
    Bhalla, Narinder
    Mclain, Kellie
    Malave, Hector
    Underberg, James
    Teague, Ralph Joe
    Garner, Hollye
    Winegar, Deborah
    Pourfarzib, Ray
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1360 - E1360
  • [4] LDL Particle Number (LDL-P) Distribution in Hypertensive Patients
    Richard F, Wright
    Ray, Pourfarzib
    Deborah A, Winegar
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15
  • [5] 不仅要关注LDL-C，还要关注LDL-P
    周颋
    家庭医药就医选药., 2022, (09) : 21 - 21
  • [6] CHOLESTEROL ABSORPTION AND APO-E PHENOTYPES REGULATE LDL CHOLESTEROL AND LDL APO-B KINETIC RESPONSES TO DIETARY-FAT AND CHOLESTEROL
    GYLLING, H
    VANHANEN, H
    OLLUS, A
    MIETINEN, TA
    ARTERIOSCLEROSIS, 1989, 9 (05): : A736 - A736
  • [7] UNLOCKING THE LIPID PUZZLE: DECIPHERING DISCORDANCE AMONG LDL, NON-HDL, LDL-P, AND APOB VALUES AND THEIR IMPACT ON CARDIOVASCULAR RISK ASSESSMENT
    Hassan, Sharjeel
    Triffon, Douglas W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1849 - 1849
  • [8] Coffee, LDL-cholesterol and cardiovascular risk
    La Sala, Lucia
    Pontiroli, Antonio E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (09) : 2735 - 2736
  • [9] Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL
    Hattori, Y
    Suzuki, M
    Tsushima, M
    Yoshida, M
    Tokunaga, Y
    Wang, Y
    Zhao, D
    Takeuchi, M
    Hara, Y
    Ryomoto, KI
    Ikebuchi, M
    Kishioka, H
    Mannami, T
    Baba, S
    Harano, Y
    ATHEROSCLEROSIS, 1998, 138 (02) : 289 - 299
  • [10] IMPACT OF EVOLOCUMAB THERAPY IN PATIENTS WITH DISCORDANCE BETWEEN LDL-C AND LDL-P
    Toth, Peter P.
    Sattar, Naveed
    Blom, Dirk
    Martin, Seth
    Jones, Steven
    Monsalvo, Maria Laura
    Elliott, Mary
    Somaratne, Ransi
    Preiss, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1718 - 1718
12345